Uterine Sarcoma: Clinical Trials

3 trials for Uterine Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1

Follow Uterine Sarcoma: new trials by email Literature Review of Uterine Sarcoma trials Research Report on Uterine Sarcoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Elacestrant - Uterine Sarcoma, Uterine Leiomyosarcoma
Phase 2RecruitingDana-Farber Cancer Institute302026-03-252026-05-22
IRCI Gynae Sarcomas, High Grade Uterine Sarcoma
Cabozantinib, Placebo - Uterine Sarcoma
Phase 2CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC582015-02-022025-08-01
Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma
Trabectedin, Drug: holiday - Soft Tissue Sarcoma, Uterine Sarcoma
Phase 2CompletedCentre Oscar Lambret532011-02-012026-03-16

Narrower conditions

Adenosarcoma of the uterus (1)  ·  Neoplasm Metastasis (1)  ·  Perivascular Epithelioid Cell Neoplasms (1)  ·  Sarcoma (1)  ·  Sarcoma, Endometrial Stromal (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Endometrial Neoplasms (1)  ·  Endometrial Stromal Tumors (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Neoplasms, Complex and Mixed (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sarcoma (1)

Interventions

RAD1901 (1)  ·  Trabectedin (1)  ·  Treatment Interruption (1)  ·  cabozantinib (1)  ·  elacestrant (1)

Sponsors

Centre Oscar Lambret (1)  ·  Dana-Farber Cancer Institute (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)

Countries

France (2)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Isabelle Ray-Coquard, MD (1)  ·  Nicholas Reed, MD (1)  ·  Suzanne George, MD (1)

Results publications

PMID 25680558, PMID 32546554, PMID 34009140